United States District Court, D. Minnesota
December 1, 2014
Dianna Clifton and Ken Clifton, Plaintiffs,
Novartis Pharmaceuticals Corporation, Defendant
For Dianna Clifton, Ken Clifton, Plaintiffs: Yvonne M Flaherty, Lockridge Grindal Nauen PLLP, Mpls, MN.
For Novartis Pharmaceuticals Corporation, Defendant: Katharine Ruth Latimer, LEAD ATTORNEY, PRO HAC VICE, Hollingsworth LLP, Washington, DC; M Joseph Winebrenner, Faegre Baker Daniels LLP, Mpls, MN.
David S. Doty, United States District Judge.
On October 28, 2014, the court requested briefing from the parties regarding whether transfer was appropriate under 28 U.S.C. § 1404(a) and, if so, to which district the action should be transferred. The parties concur that the case should be transferred to the United States District Court for the District of Arizona. The court agrees.
Transferring this case will promote the interests of justice and the convenience of the parties. Plaintiff Ken Clifton resides within the District Arizona. The majority of Dianna Clifton's healthcare providers also reside in Arizona. The majority of events giving rise to this lawsuit occurred in Arizona. Indeed, defendant concedes that Arizona has the closest connection to this case. Moreover, neither party argues that a transfer will result in prejudice, and the court foresees none. The main effect of a transfer will be to place the parties in a forum that has some connection to the underlying dispute and is more convenient for the parties. As a result, transfer to the District of Arizona is the just outcome.
Accordingly, based upon the files, records, and proceedings herein, IT IS HEREBY ORDERED that this case is transferred to the United States District Court for the District of Arizona.